Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors due to its ability to cross cell membranes and inhibit specific signaling pathways. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity. Currently under investigation for use in targeted therapies with reduced side effects compared to conventional chemotherapy.